Patents Assigned to CEVA SANTE ANIMALE SA
  • Publication number: 20110245261
    Abstract: This present invention relates to an antiprolactinic veterinary composition to be administered to ruminants. Said composition comprises at least one antiprolactinic compound which is an agonist of dopamine receptors, and is particularly useful for promoting a substantial reduction of lactation, mammary involution, and for treating and/or intra-mammary diseases or infections of ruminants.
    Type: Application
    Filed: April 7, 2011
    Publication date: October 6, 2011
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Anouck LAGARDE, Stephane FLOCH, Thierry BERTAIM
  • Publication number: 20110223195
    Abstract: The invention relates to vaccine compositions comprising chitosan and a vaccine which are administered to avian species via the ocular route, and methods or programs of vaccination including use of chitosan in order to increase or enhance cell-mediated immunity in avian species and persistence of the vaccine avian tissues.
    Type: Application
    Filed: September 4, 2009
    Publication date: September 15, 2011
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Yannick Gardin, Vilmos Palya, Sylvain Comte
  • Publication number: 20110092560
    Abstract: This invention describes a new topical formulation (spot-on) for controlling ectoparasites in cats and dogs, which comprises the active ingredient Fipronil and/or the derivates and salts thereof, as well as antioxidants and a suitable vehicle. The use of an organic solvent acting as the transdermal carrier provides this product with a longer residual period and, consequently, higher efficacy.
    Type: Application
    Filed: June 16, 2009
    Publication date: April 21, 2011
    Applicant: CEVA SANTE ANIMALE SA
    Inventor: Mauricio Del Bigio
  • Publication number: 20110077301
    Abstract: Mixture of fatty acids, their derivatives, ester or methyl ester derivates thereof, which may be administered to non-human mammals by diffusion in to ambient air during at least seven consecutive days, with a rapid kinetic of diffusion during the first three days of administration.
    Type: Application
    Filed: May 29, 2009
    Publication date: March 31, 2011
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Benedicte Deminiere, Sandrine Lacoste, Marie-Laure Loubiere
  • Publication number: 20100183718
    Abstract: The invention relates to novel compositions including an aldosterone antagonist and administered according to a predetermined dosage for treating heart deficiency in non-human mammals.
    Type: Application
    Filed: June 25, 2008
    Publication date: July 22, 2010
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet
  • Publication number: 20090270356
    Abstract: The invention relates to new compositions comprising an aldosterone antagonist according to a particular posology for the treatment of heart failure in non-human mammal animals.
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet